Related Experiment Video

Updated: Jun 23, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Successful dissolution of cholesterol gallstone during treatment with pravastatin

J W Smit1, K J van Erpecum, M F Stolk

  • 1Department of Internal Medicine, University Hospital Utrecht, The Netherlands.

Gastroenterology
|September 1, 1992
PubMed

Insights

This case report shows pravastatin effectively dissolved a large cholesterol gallstone in a hypercholesterolemic patient. This cholesterol-lowering drug normalized serum cholesterol and reduced biliary saturation, offering a nonsurgical treatment option.

Area of Science:

  • Gastroenterology and Hepatology
  • Pharmacology

Background:

  • Cholesterol gallstone disease affects a significant portion of the population.
  • Hypercholesterolemia is a known risk factor for cholesterol gallstone formation.
  • Current nonsurgical treatments for gallstones have limitations.

Observation:

  • A 51-year-old male patient with hypercholesterolemia presented with a large solitary cholesterol gallstone.
  • The patient was treated with pravastatin, a 3-hydroxy 3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, at a dosage of 40 mg/day.
  • Treatment duration was 3 months.

Findings:

  • Serum cholesterol levels normalized from 7.7 mmol/L to 5.2 mmol/L.
  • Biliary cholesterol saturation index decreased from 1.3 to 0.8.
  • Repeated ultrasonography confirmed complete dissolution of the cholesterol gallstone.

Implications:

  • Pravastatin demonstrates potential as a nonsurgical therapeutic agent for cholesterol gallstone disease.
  • This approach is particularly relevant for patients with coexisting hypercholesterolemia requiring HMG-CoA reductase inhibitor therapy.
  • Further research may explore the efficacy of statins in managing gallstone disease.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...